Blodgett Wealth Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.07M Hold
4,395
0.85% 23
2025
Q4
$910K Hold
4,395
0.63% 28
2025
Q3
$815K Buy
4,395
+1
+0% +$171 0.56% 28
2025
Q2
$671K Sell
4,394
-500
-10% -$76.9K 0.53% 30
2025
Q1
$812K Buy
4,894
+106
+2% +$16.6K 0.69% 28
2024
Q4
$692K Hold
4,788
0.54% 29
2024
Q3
$776K Sell
4,788
-96
-2% -$15.3K 0.65% 25
2024
Q2
$714K Sell
4,884
-2,196
-31% -$327K 0.6% 24
2024
Q1
$1.12M Sell
7,080
-3,857
-35% -$614K 1.01% 19
2023
Q4
$1.71M Sell
10,937
-298
-3% -$45.7K 1.75% 13
2023
Q3
$1.75M Buy
11,235
+1
+0% +$165 1.92% 14
2023
Q2
$1.86M Sell
11,234
-92
-0.8% -$14.8K 1.92% 13
2023
Q1
$1.76M Buy
11,326
+2
+0% +$323 2.03% 13
2022
Q4
$2M Buy
11,324
+52
+0.5% +$8.98K 2.43% 9
2022
Q3
$1.84M Buy
11,272
+1
+0% +$169 2.21% 9
2022
Q2
$2M Buy
11,271
+2
+0% +$356 2.19% 11
2022
Q1
$2M Sell
11,269
-499
-4% -$84.9K 1.66% 13
2021
Q4
$2.01M Buy
+11,768
New +$1.93M 1.56% 14

Other funds holding JNJ

Blodgett Wealth Advisors's JNJ Position: Q1 2026 in Review

Blodgett Wealth Advisors held its Johnson & Johnson (JNJ) position steady in Q1 2026 at 4,395 shares worth $1.07M. The position accounts for 0.85% of the portfolio, ranked #23.

Blodgett Wealth Advisors first reported a position in JNJ in Q4 2021 and has held it in 18 quarters since. The position peaked at $2.01M in Q4 2021. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Blodgett Wealth Advisors held 4,395 shares of Johnson & Johnson worth $1.07M as of Q1 2026.
  • Blodgett Wealth Advisors left its Johnson & Johnson share count unchanged in Q1 2026.
  • Johnson & Johnson made up 0.85% of Blodgett Wealth Advisors's portfolio in Q1 2026, its #23 holding.
  • Blodgett Wealth Advisors first reported a position in Johnson & Johnson in Q4 2021 and has held it in 18 quarters since.
  • Blodgett Wealth Advisors's Johnson & Johnson position peaked at $2.01M in Q4 2021.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Blodgett Wealth Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.